Osmosis Investment Management UK Ltd Buys New Holdings in Corteva, Inc. $CTVA

Osmosis Investment Management UK Ltd purchased a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 6,479 shares of the company’s stock, valued at approximately $549,000.

A number of other institutional investors also recently bought and sold shares of the business. Compass Financial Management LLC purchased a new stake in shares of Corteva in the 2nd quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the third quarter worth $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva during the fourth quarter worth $27,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva during the fourth quarter worth $28,000. Finally, Cornerstone Financial Management LLC acquired a new position in Corteva during the fourth quarter valued at $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on CTVA shares. BMO Capital Markets upped their price target on shares of Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Bank of America boosted their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Mizuho upped their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Rothschild & Co Redburn raised their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $91.50.

Corteva Stock Up 0.4%

CTVA stock opened at $83.18 on Wednesday. The firm has a market cap of $55.50 billion, a PE ratio of 55.09, a P/E/G ratio of 2.54 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm’s fifty day moving average is $82.39 and its 200 day moving average is $80.37. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the prior year, the firm posted $2.20 earnings per share. The company’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.